Discover

VACH
Voyager Acquisition Corp.
12.90
1 x 13.00
1 x 13.10
bid
ask
+
0.00
0.00%
03:59 PM
timesize
Ytd20.90%
1y24.16%
10.50
day range
12.99
1.72
52 week range
27.36
Open10.60Prev Close12.90Low10.50High12.99Mkt Cap68.94M
Vol0.00Avg Vol15.52KEPS0.21P/E10.38Forward P/EN/A
Beta-0.40Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning09-2650-d Avg12.31200-d Avg11.071yr Est0.00

VACH News

benzinga.com
VERAXA Biotech And Voyager Acquisition Complete Business Combination; On June 11, 2026, VERAXA Will

Business combination transaction with Voyager Acquisition Corp. complete, creating a Nasdaq-listed,

VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
globenewswire.com
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on

The business combination of VERAXA Biotech and Voyager Acquisition Corp. was closed successfully and

Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Marke

US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering t

VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
globenewswire.com
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Not

Transactions Provide Financial Flexibility to Advance Pipeline of Next Generation Cancer Therapies C

GE Vernova, Boston Scientific, Intuitive Surgical And Other Big Stocks Moving Higher On Wednesday
benzinga.com
GE Vernova, Boston Scientific, Intuitive Surgical And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones gaining over 350 points on Wednesday. GE Vernova shares

Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday

Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV

Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday
benzinga.com
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4

benzinga.com
Voyager Shareholders Approve Merger With VERAXA Biotech, Expected To Go Public On Nasdaq Under 'VRXA

Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voy

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG
globenewswire.com
Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech A

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,”

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
globenewswire.com
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combina

BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,”

Crossingbridge Advisors LLC Acquires Shares of 46,779 Voyager Acquisition Corp. $VACH
defenseworld.net
Crossingbridge Advisors LLC Acquires Shares of 46,779 Voyager Acquisition Corp. $VACH

Crossingbridge Advisors LLC acquired a new position in shares of Voyager Acquisition Corp. (NASDAQ:

VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.
globenewswire.com
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.

VERAXA shareholders approve merger & issuance of new shares to Voyager. Both resolutions are prerequ

Contrasting Blaize (NASDAQ:BZAI) & Voyager Acquisition (NASDAQ:VACH)
defenseworld.net
Contrasting Blaize (NASDAQ:BZAI) & Voyager Acquisition (NASDAQ:VACH)

Blaize (NASDAQ: BZAI - Get Free Report) and Voyager Acquisition (NASDAQ: VACH - Get Free Report) are

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VACH, and EFIN
prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VA

NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & As

VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology
globenewswire.com
VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in I

Partnership combines Secarna's OligoCreator® platform with VERAXA's technology suite to create next-

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
globenewswire.com
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with

ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
globenewswire.com
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with

ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging lea

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
globenewswire.com
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Ad

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
globenewswire.com
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Ad

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
globenewswire.com
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats